http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021268251-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a49836259fc49413377e142f102ffab
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B90-361
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2090-373
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B90-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2090-3941
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0082
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2039-0009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2039-0238
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2576-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2090-3937
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-684
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M39-0208
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B90-90
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M39-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M39-02
filingDate 2019-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bd59a2681e8160ee310347473ff3d7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15a0734bf43dc95c969d901e7558c6b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_303b3524daeb7386e12c7f20cd661a74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad42e11ea6f51df2de0d956096b27d2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c29a3c62c3f57206e13ae4f6cdc183af
publicationDate 2021-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2021268251-A1
titleOfInvention Implantable Ports, Implantable Port-Detecting Devices, and Methods Thereof
abstract Disclosed herein is an implantable port and an implantable port-detecting device (“IPDD”). The implantable port includes a housing and a septum over a portion of the housing. At least one of the housing or the septum incorporates a contrast agent for locating the septum of the implantable port when the implantable port is implanted in a patient. The IPDD includes a light source, a light detector, and a display configured to display a presence of the implantable port. The light source is configured to emit light in a near-infrared (“NIR”) range of wavelengths as incident light for absorption by the contrast agent. The light detector is configured to detect light in the NIR range of wavelengths including luminescent light emitted by the contrast agent. The display is configured to display a presence of the implantable port when the luminescent light from the contrast agent is detected by the light detector.
priorityDate 2018-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID482532689
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474445
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555088
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID311
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171548

Total number of triples: 38.